122 related articles for article (PubMed ID: 9124595)
1. Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period.
Bloch KD; Filippov G; Sanchez LS; Nakane M; de la Monte SM
Am J Physiol; 1997 Mar; 272(3 Pt 1):L400-6. PubMed ID: 9124595
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells.
Filippov G; Bloch DB; Bloch KD
J Clin Invest; 1997 Aug; 100(4):942-8. PubMed ID: 9259594
[TBL] [Abstract][Full Text] [Related]
3. Soluble guanylate cyclase gene expression and localization in rat lung after exposure to hypoxia.
Li D; Zhou N; Johns RA
Am J Physiol; 1999 Oct; 277(4):L841-7. PubMed ID: 10516227
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia decreases expression of soluble guanylate cyclase in cultured rat pulmonary artery smooth muscle cells.
Hassoun PM; Filippov G; Fogel M; Donaldson C; Kayyali US; Shimoda LA; Bloch KD
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):908-13. PubMed ID: 14754757
[TBL] [Abstract][Full Text] [Related]
5. Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development.
Sanchez LS; de la Monte SM; Filippov G; Jones RC; Zapol WM; Bloch KD
Pediatr Res; 1998 Feb; 43(2):163-8. PubMed ID: 9475279
[TBL] [Abstract][Full Text] [Related]
6. Sustained nitric oxide exposure decreases soluble guanylate cyclase mRNA and enzyme activity in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Sep; 79(1):66-70. PubMed ID: 9735242
[TBL] [Abstract][Full Text] [Related]
7. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
[TBL] [Abstract][Full Text] [Related]
9. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat.
Xia XD; Xu ZJ; Hu XG; Wu CY; Dai YR; Yang L
Cell Biochem Funct; 2012 Jun; 30(4):279-85. PubMed ID: 22290599
[TBL] [Abstract][Full Text] [Related]
10. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
[TBL] [Abstract][Full Text] [Related]
11. Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms.
Takata M; Filippov G; Liu H; Ichinose F; Janssens S; Bloch DB; Bloch KD
Am J Physiol Lung Cell Mol Physiol; 2001 Feb; 280(2):L272-8. PubMed ID: 11159006
[TBL] [Abstract][Full Text] [Related]
12. [Study on soluble guanylate cyclase in pulmonary hypertension rat model].
Xia XD; Xu ZJ; Bi YT; Dai YR; Wu SZ
Zhonghua Nei Ke Za Zhi; 2003 Sep; 42(9):628-31. PubMed ID: 14514391
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta modulates the expression of nitric oxide signaling enzymes in the injured developing lung and in vascular smooth muscle cells.
Bachiller PR; Nakanishi H; Roberts JD
Am J Physiol Lung Cell Mol Physiol; 2010 Mar; 298(3):L324-34. PubMed ID: 20023176
[TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor decreases soluble guanylate cyclase in rat pheochromocytoma PC12 cells.
Liu H; Force T; Bloch KD
J Biol Chem; 1997 Feb; 272(9):6038-43. PubMed ID: 9038227
[TBL] [Abstract][Full Text] [Related]
15. Prolonged exposure of chromaffin cells to nitric oxide down-regulates the activity of soluble guanylyl cyclase and corresponding mRNA and protein levels.
Ferrero R; Torres M
BMC Biochem; 2002 Sep; 3():26. PubMed ID: 12350235
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.
Schermuly RT; Stasch JP; Pullamsetti SS; Middendorff R; Müller D; Schlüter KD; Dingendorf A; Hackemack S; Kolosionek E; Kaulen C; Dumitrascu R; Weissmann N; Mittendorf J; Klepetko W; Seeger W; Ghofrani HA; Grimminger F
Eur Respir J; 2008 Oct; 32(4):881-91. PubMed ID: 18550612
[TBL] [Abstract][Full Text] [Related]
17. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents.
Papapetropoulos A; Marczin N; Mora G; Milici A; Murad F; Catravas JD
Hypertension; 1995 Oct; 26(4):696-704. PubMed ID: 7558233
[TBL] [Abstract][Full Text] [Related]
18. Tirofiban increases soluble guanylate cyclase in rat vascular walls: pharmacological and pathophysiological consequences.
Ruiz-Torres MP; Griera M; Chamorro A; Díez-Marqués ML; Rodríguez-Puyol D; Rodríguez-Puyol M
Cardiovasc Res; 2009 Apr; 82(1):125-32. PubMed ID: 19126601
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide sensitive-guanylyl cyclase subunit expression changes during estrous cycle in anterior pituitary glands.
Cabilla JP; Ronchetti SA; Nudler SI; Miler EA; Quinteros FA; Duvilanski BH
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E731-7. PubMed ID: 19141686
[TBL] [Abstract][Full Text] [Related]
20. Maturational changes in the regulation of pulmonary vascular tone by nitric oxide in neonatal rats.
Chicoine LG; Paffett ML; Girton MR; Metropoulus MJ; Joshi MS; Bauer JA; Nelin LD; Resta TC; Walker BR
Am J Physiol Lung Cell Mol Physiol; 2007 Nov; 293(5):L1261-70. PubMed ID: 17827249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
